We have a limited company client who has a fixed asset investement in quoted shares, under the FRSSE we have held it at cost (with disclosure), under FRS102 we will be showing it at market value.
I assume any increase in value will go to the P&L but won't be subject to CT until the gain is realised, but I can't see a definitive statement of this.
Does this sound correct? And does anyone have a link to guidance about it?